Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options

This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with myeloproliferative neoplasms particularly myelofibrosis and polycythemia vera. All aspects of this program are designed to complement each other including an Interactive Treatment Decision Support Tool an expert-authored commentary and module and a downloadable slideset.

Share

Program Content

No activities added yet

Activities

Treatment of MF and PV
Myelofibrosis and Polycythemia Vera: Current and Emerging Treatment Options
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 08, 2017

Expires: December 31, 2024

Faculty

cover img faculity

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Incyte